ABSTRACTS

  1. Pincus SH and Klebanoff SJ: Quantitative leukocyte iodination. Clin Res 19: 185A, 1971.

  2. Stossel TP and Pincus SH: A new macrophage actin-binding protein: Evidence for its role in endocytosis. Clin Res 23: 407A, 1975.

  3. Pincus SH and Stossel TP: Macrophage plasma membrane: Association with contractile proteins. Clin Res 24: 109A, 1976.

  4. Pincus SH and Smith P: A new model for experimental eosinophil production. Clin Res 25: 100A, 1977.

  5. Pincus SH: Comparative metabolism of eosinophils and neutrophils. Clin Res 25: 345A, 1977.

  6. Pincus SH: Active eosinophil iodination. Clin Res 26:300A, 1978.

  7. Pincus SH: Eosinophil iodination: Regulation by cyclic nucleotides. Clin Res 27:244A, 1979.

  8. Pincus SH, Butterworth A, Vadas M, Robbins M, and David JR: Eosinophil specific non-oxidative killing of schistosomula. Clin Res 28:376A, 1980.

  9. Pincus SH, DiNapoli AM, Schooley WR, and Broder S: Functional heterogeneity among eosinophils. Clin Res 28:321A, 1980.

  10. Pincus SH, Schooley WR, and DiNapoli AM: Eosinophil function modulated by histamine. Clin Res 29:172A, 1981.

  11. Pincus SH, Alroy J, and Fallon J: A guinea pig model for hypereosinophilic syndrome. Clin Res 29:171A, 1981.

  12. Wyler DJ and Pincus SH: Eosinophils contain fibroblast stimulating factor. Clin Res 29:379A, 1981.

  13. Pincus SH, Vadas M. Dessein A, DiNapoli AM, and David JR: Eosinophil helminthotoxicity: Enhancement via an oxidative mechanism. Clin Res 30:376A, 1982.

  14. Jacoby W, Pincus SH, Cammarata PC, and Findlay S: Mast cell deficient mice develop immediate hypersensitivity. Clin Res 30:580A, 1982.

  15. Pincus SH, DiNapoli AM, and Rocklin R: Oxidative metabolism of eosinophils: Modulation by lymphokine(s). Clin Res 31:350A, 1983.

  16. Rocklin R, Kiselis I, and Pincus SH: Modulation of PHA-induced lymphocyte proliferation by human eosinophils (eos). Clin Res 31:540A, 1983.

  17. Pincus SH and Mier JM: Modulation of eosinophil helminthotoxicity by lymphocyte-derived factors. Clin Res 32:380A, 1984.

  18. Pincus SH, Cammarata PC, Kurtzberg L, Delima M, and Despommier D: Eosinophilia in murine trichinosis. 6 th Int Conf on Trichinellosis, McGill Univ., 1985.

  19. Pincus SH, Whitcomb E, Rocklin R, and Dinarello CA: Interleukin 1 enhances eosinophil function. Clin Res 33:385A, 1985.

  20. Ramesh KS , Pincus SH, and Rocklin R: Characterization of a lymphocyte inhibitory factor derived from activated eosinophils. Clin Res 33:386A, 1985.

  21. Konnikov N, Dinarello CA, and Pincus SH: UVB therapy increases interleukin-1 (IL-1) in vivo. Clin Res 39:760A, 1986.

  22. Pincus SH, Whitcomb EA, and Dinarello CA: Interleukin-1 (IL-1) increases lymphocyte intracellular Ca++. Clin Res 39:503A, 1986.

  23. Pincus SH, Whitcomb EA, and Dinarello CA: Interaction of interleukin-1 (IL-1) and PMA in modulation of eosinophil function: Implications for IL-1 mechanism of action. Lymphokine Res 6:1208, 1987.

  24. Konnikov N, Dinarello CA, and Pincus SH: Ultraviolet B (UVB) therapy increases human plasma interleukin-1 (IL-1) levels. Lymphokine Res 6:1209, 1987.

  25. Holick, MF, Smith EL, and Pincus SH: A new approach for the treatment of psoriasis: Topical or oral use of 1,25-dihydroxyvitamin D3 may be a safe and effective therapy for psoriasis. Clin Res 35(3):581A, 1987.

  26. Konnikov N, Ree HJ, Dinarello CA, and Pincus SH: Interleukin-1 (IL-1) is present in psoriatic plaques. Clin Res 35(3):696A, 1987.

  27. Romero L, Pincus SH: Interleukin-6 is increased in atrophic cutaneous disease. Clin Res 37(2):694A, 1989.

  28. Birkland T, Cheavens M, Pincus SH: Human eosinophils stimulate fibroblast growth. Clin Res 39(3):675A, 1991.

  29. Goldman B, Fujihara K, Bisaccia E, Pincus S, Greenberg SJ, and Oseroff AR: HTLV retroviral homologous sequences in mycosis fungoides/Sezary syndrome. J Invest Dermatol 98:660A, 1992.

  30. Birkland T, Cheavens M, Pincus SH: Human eosinophils stimulate fibroblast growth. Clin Res 40(2):465A, 1992.

  31. Birkland T, Oseroff A, Pincus S: Human eosinophils (EOS) are cytotoxic to a carcinoma cell line. Clin Res 4(3):669A, 1992.

  32. Wehr R, Gibson J, Epinette W, Chesnut C, Goffe B, Katz I, Fridley MN, Lazarus G, Lowe N, Pincus S: The safety of topically applied calcipotriene ointment 0.005% (a vitamin D 2 analogue) as measured by blood, urine and bone density analysis in psoriatic patients. Skin Pharm Soc Proc., 1993.

  33. Birkland T, Solecki D, Oseroff A, Pincus S: Tumor cell cytotoxicity is mediated by human eosinophils (EOS). Clin Res 41(2):468A, 1993.

  34. Oseroff AR, Chatterjee M, Russell D, Vaikus L, Pincus SH, Stoll H, Beers TF, Kohler H, Foon KA: Monoclonal anti-idiotype vaccine therapy for cutaneous T cell lymphoma. J Invest Derm 101:414A, 1993.

  35. Birkland TP, Solecki D, Oseroff AR, Pincus SH: Cytokine modulation of eosinophil-mediated cytotoxicity. Clin Res 41:609A, 1993.

  36. Pincus S, Oseroff A, Breneman D, Foss F. Koh H, Duvic M. Vonderheid EC, Coe B, Phillips SB, Bernstein JE: Effectiveness of topical Naloxone HCL, 0.05%, in the treatment of pruritus associated with mycosis fungoides (MF) and Sezary syndrome (SS). J Invest Derm 104:661, 1995.

  37. Spellman MC, Piacquadio DJ, Pincus S: Azelaic acid and glycolic acid combination for mild to moderate acne. Am Acad of Derm meeting, 1998.

  38. Lowe NJ , Grimes P, Pincus S, d Harper H: Efficacy and safety of azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker skinned patients. Am Acad of Derm meeting, 1998.

  39. Pincus S, Holland G, Keitz S, Aron D, Cannon G: Learners’ Perceptions of Clinical Training Experience in Veterans Affairs Medical Centers. Scientific Poster Presentation for Innovations in Medical Education Section. Society of General Internal Medicine annual meeting, 2002.

  40. Keitz S, Holland G, Aron D, Cannon G, and Pincus S.  Learners’ Perceptions of Physician Resident Training Experience in Veterans Affairs (VA) Medical Centers.  Scientific Poster Presentation.  Association of American Medical Colleges (AAMC) Annual Meeting, 2002.

  41. Holland G, Aron D, Cannon G, Gilman S, Graber M, Kaminetzky C, Keitz S, Melander E, Mickey D, and Pincus S.  National Physician Resident Learners’ Perceptions Survey. IME Section of the AAMC Annual Meeting, 2002.

  42. Buchanan R, Holland G, Melander E, Mickey D, and Pincus S.  Learners’ Perceptions of Dental Trainees in VA and non-VA Institutions.  Exhibit Presentation.  American Dental Education Association Annual Meeting, 2002.

  43. Chang BK, Kashner TM, Holland GJ, Mickey D, Berkowitz A, Hinson R, Melander E, Pincus SH, and Sanders KM.  Methods to Study the Geographic Distribution of Physician Residents in the VA System.  Poster Presentation. AAMC Physician Workforce Research Conference, May 2005.

  44. Pincus SH.  Women in the Physician Workforce:  Can the United States Learn from International Experiences?  AAMC Physician Workforce Research Conference, May 2005.

  45. Pincus SH.  Women in the Physician Workforce: Implications for Workforce Planning Women in the International Physician Workforce.  AAMC Physician Workforce Research Conference, May 2005.         

  46. Kashner TM, Chang BK, Holland GJ, Hinson RS, Melander E, Mickey D, Kashner T, Sanders KM, and Pincus SH.  Do Residents Contribute to Clinical Care?  AAMC Physician Workforce Research Conference, May 2005.

  47. Pincus SH. Gender and Generations: Anticipating Changes in Physician Expectations. AAMC Physician Workforce Research Conference, May 2006.

  48. Pincus SH and Haseltine F. Improving Recognition and Enhancing Rewards, AAMC Physician Workforce Research Conference, May 2007.

  49. Pincus SH, Schick V, Haseltine F. The RAISE Project. Poster Presentation at National Leadership Workshop on Mentoring Women in Biomedical Careers, November 2007.